Equity Overview
Price & Market Data
Price: $2.49
Daily Change: -$0.215 / 8.65%
Daily Range: $2.44 - $2.69
Market Cap: $102,095,472
Daily Volume: 148,403
Performance Metrics
1 Week: -6.93%
1 Month: 42.82%
3 Months: 132.2%
6 Months: 58.28%
1 Year: 12.95%
YTD: 47.92%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.